See also this year's filing and all EDGAR filings for this company.
PDF Report 0001261249_2021_Agile_Therapeutics_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001261249, Agile Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 56,785,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 14,243,000 |
| 3 | remainder_Assets | 2,034,000 |
| 4 | LiabilitiesCurrent | 7,353,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 16,381,000 |
| 7 | CostOfGoodsAndServicesSold | 282,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 13,205,220 |
| 9 | ResearchAndDevelopmentExpense | 15,927,644 |
| 10 | remainder_Expenses | 13,863,903 |
| 11 | remainder_Revenues | 749,000 |
| 12 | remainder_NetIncome | 217,443 |
| 13 | remainder_ComprehensiveNetIncome | 3,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 73,062,000 |
| 1 | Liabilities | 23,734,000 |
| 2 | Expenses | 43,278,767 |
| 3 | Revenues | 749,000 |
| 4 | StockholdersEquity | 49,328,000 |
| 5 | NetIncome | -42,312,324 |
| 6 | ComprehensiveNetIncome | -42,310,824 |
| 7 | BaseVar | 70,522,105 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.35 |
| 9 | EconomicCapitalRatio | 2.57 |